Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
ANGLE plc Company Overview 5
ANGLE plc Company Snapshot 5
ANGLE plc Pipeline Products and Ongoing Clinical Trials Overview 5
ANGLE plc – Pipeline Analysis Overview 8
ANGLE plc – Key Facts 8
ANGLE plc – Major Products and Services 9
ANGLE plc Pipeline Products by Development Stage 10
ANGLE plc Ongoing Clinical Trials by Trial Status 12
ANGLE plc Pipeline Products Overview 14
Parsortix GEN2 14
Parsortix GEN2 Product Overview 14
Parsortix System 15
Parsortix System Product Overview 15
Parsortix-Based Test – Breast Cancer 16
Parsortix-Based Test – Breast Cancer Product Overview 16
Parsortix-Based Test – Colorectal Cancer 17
Parsortix-Based Test – Colorectal Cancer Product Overview 17
Parsortix-Based Test – Head & Neck Cancer 18
Parsortix-Based Test – Head & Neck Cancer Product Overview 18
Parsortix-Based Test – Lung Cancer 19
Parsortix-Based Test – Lung Cancer Product Overview 19
Parsortix-Based Test – Ovarian Cancer Triage 20
Parsortix-Based Test – Ovarian Cancer Triage Product Overview 20
Parsortix-Based Test – Ovarian Cancer Triage Clinical Trial 21
Parsortix-Based Test – Pancreatic Cancer 22
Parsortix-Based Test – Pancreatic Cancer Product Overview 22
Parsortix-Based Test – Prostate Cancer 23
Parsortix-Based Test – Prostate Cancer Product Overview 23
ANGLE plc – Key Competitors 24
ANGLE plc – Key Employees 25
ANGLE plc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
ANGLE plc, Recent Developments 27
Jun 04, 2018: ANGLE: Encouraging Progress in ANG-002 FDA Clinical Study 27
May 14, 2018: Angle Appoints Leading NHS Prostate Cancer Surgeon As Scientific Advisor 27
May 03, 2018: Angle and Qiagen Present Poster at Leading Cancer Conference Demonstrating Utility of Angle”s Parsortix System in Conjunction With Qiagen”s Adnatest Assay 28
Apr 19, 2018: Angle”s Parsortix System Showcased In Multiple Presentations At Leading Cancer Conference AACR 2018 28
Apr 19, 2018: Breakthrough Research Demonstrates Parsortix Workflow For Culturing Circulating Tumor Cells For In-Vitro Drug Testing 29
Apr 05, 2018: First Patient Enrolled In Clinical Study To Support FDA Clearance Of The Parsortix System 30
Mar 26, 2018: Angle”S Ovarian Cancer Risk Assessment Achieves The Highest Sensitivity And Specificity For Predicting Cancer 30
Feb 06, 2018: ANGLE: Research Grant From Abbott 31
Jan 31, 2018: ANGLE: Interim Results for the six months ended 31 October 2017 32
Jan 16, 2018: ANGLE: Webinar: Using The Parsortixtm System To Identify Drugs That May Arrest Cancer Metastasis 33
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37
ANGLE plc Pipeline Products and Ongoing Clinical Trials Overview 5
ANGLE plc Pipeline Products by Equipment Type 6
ANGLE plc Pipeline Products by Indication 7
ANGLE plc Ongoing Clinical Trials by Trial Status 7
ANGLE plc, Key Facts 8
ANGLE plc, Major Products and Services 9
ANGLE plc Number of Pipeline Products by Development Stage 10
ANGLE plc Pipeline Products Summary by Development Stage 11
ANGLE plc Ongoing Clinical Trials by Trial Status 12
ANGLE plc Ongoing Clinical Trials Summary 13
Parsortix GEN2 - Product Status 14
Parsortix GEN2 - Product Description 14
Parsortix System - Product Status 15
Parsortix System - Product Description 15
Parsortix-Based Test - Breast Cancer - Product Status 16
Parsortix-Based Test - Breast Cancer - Product Description 16
Parsortix-Based Test - Colorectal Cancer - Product Status 17
Parsortix-Based Test - Colorectal Cancer - Product Description 17
Parsortix-Based Test - Head & Neck Cancer - Product Status 18
Parsortix-Based Test - Head & Neck Cancer - Product Description 18
Parsortix-Based Test - Lung Cancer - Product Status 19
Parsortix-Based Test - Lung Cancer - Product Description 19
Parsortix-Based Test - Ovarian Cancer Triage - Product Status 20
Parsortix-Based Test - Ovarian Cancer Triage - Product Description 20
Parsortix-Based Test - Ovarian Cancer Triage - Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting with a Pelvic Mass: ANG-003 EMBER Study 21
Parsortix-Based Test - Pancreatic Cancer - Product Status 22
Parsortix-Based Test - Pancreatic Cancer - Product Description 22
Parsortix-Based Test - Prostate Cancer - Product Status 23
Parsortix-Based Test - Prostate Cancer - Product Description 23
ANGLE Plc, Key Employees 25
ANGLE Plc, Other Locations 26
Glossary 36
List of Figures
ANGLE plc Pipeline Products by Equipment Type 6
ANGLE plc Pipeline Products by Development Stage 10
ANGLE plc Ongoing Clinical Trials by Trial Status 12